ET Healthcare

ET Healthcare unveiled the NAPA point-of-care analyzer at #MedLabMiddleEast2025 in Dubai. This fully automated device features second-generation Test-on-a-Probe (TOP) biosensor technology, delivering high-sensitivity troponin testing from whole blood in just 10 minutes. Designed to enhance emergency room efficiency, NAPA aims to provide rapid, accurate diagnostics, improving patient care while reducing costs. #HealthcareInnovation #MedTech

The Cardiovascular Biomarker Standardization and Application Task Force (hereinafter referred to CTF-CB) was officially established in China on January 26, 2024. CTF-CB is a non-exclusive, public welfare organization composed of experts from the fields of research and development, preparation, standardization, testing, and clinical application. To help medical laboratories in selecting “Real high-sensitivity troponin” reagents, CTF-CB developed the “China Cardiac Troponin Performance Checklist”. Pylon hs-TnI and hs-TnT both are included with peer-reviewed data.

The #National_Medical_Products_Administration (#NMPA) recently issued the industry standard YY/T 1233-2024 for “Cardiac Troponin detection reagent kit (labelling Immunoassay)." Developed by organizations including the Beijing Institute of Medical Device Testing, Jiangsu Institute of Medical Device Testing, National Institutes for Food and Drug Control, Fuwai Hospital CAMS & PUMC, ET Healthcare, Mindray, and Abbott, the standard will take effect on October 15, 2025. The updated standard introduces detection limit requirements: hs-cTnI must not exceed 5.0 ng/L, and hs-cTnT must not exceed 8.0 ng/L. ET Healthcare's hs-cTnI has a detection limit of 0.5 ng/L, and hs-cTnT has a detection limit of 3 ng/L, both of which comply with the new standard. This standard will enhance the precision of Cardiac Troponin testing, unify performance criteria across products, and help companies establish key technical parameters for product development and quality control, ultimately improving overall testing quality.

We will be participating in the Global Health Exhibition this October in Saudi Arabia. Look forward to connecting with you there! Check out these keywords to get a head start on your exploration: Fully Automated, For Emergency/POC Lab, Widest Cardiac Panel(12) , IFCC verified, Single-Test-Format, Whole blood mode, CE approved, SFDA approval #GlobalHealthExhibiton

Chest pain and cardiac discomfort are common in emergency departments, representing 20-25% of global admissions. These symptoms may indicate serious #cardiovascular conditions, including acute myocardial infarction (AMI) and heart failure. We take pride in our ability to deliver accuate and quick diagnostic solutions with cardiac markers such as high-sensitivity troponin, BNP, and NT-proBNP, crucial for early diagnosis, risk stratification, and personalized treatment. #WorldHeartDay #CardiovascularDisease

#Pylon: A Reliable Choice! Each year, thousands of leading and emerging laboratories select the most dependable platforms for their External Quality Assessment (EQA) program, facilitated by the National Center for Clinical Laboratory (NCCL) in China. Pylon continues to show notable strength in PCT assays, reinforcing its reputation for reliability and stability.

National Center for Clinical Laboratory (NCCL, China) released #External_Quality_Assessment (EQA) statistics for the first half of this year. Thousands of leading and emerging laboratories participate in EQA programs annually, to demonstrate their commitment to quality and accuracy, ensuring dependable test results and improved patient care. Undoubtedly, laboratories select the most reliable platforms. Once again, Pylon Platform achieved impressive results, reaffirming its status as a top choice among laboratories.

📣 The groundbreaking clinical research outcomes of the partnership between ET Healthcare and four prestigious Class A hospitals in China are set to be featured in Clinical Chemistry. Excitingly, two of these studies will be highlighted at the upcoming #ADLM2024 conference. Step into the poster area for an in-depth exploration! 1️⃣ 📑 Analytical performances of a novel fluorescent immunoassay of anti-Müllerian hormone and establishment of the reference intervals in Chinese children.  🏥 Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine 2️⃣ 📑 Change of sST2 and NT-proBNP levels predict early cardiovascular toxicity in breast cancer patients treated with anthracycline-containing chemotherapy 🏥 Fudan University Shanghai Cancer Center, Shanghai 3️⃣ 📑 Evaluation of IL-6, D-Dimer, and S100β as clinical biomarkers for severity and prognosis of subarachnoid hemorrhage patients: A retrospective study. 🏥 Sichuan Academy of Medical Sciences · Sichuan Provincial People's Hospital 4️⃣ 📑 Establishing a reference interval for soluble ST2 in healthy Chinese Adults and its Analytical Performance in chronic kidney disease coexisting with heart failure. 🏥 HanDan Central Hospital #ADLM2024 #ETHealthcare #ClinicalChemistry #Networking

📣 The groundbreaking clinical research outcomes of the partnership between ET Healthcare and four prestigious Class A hospitals in China are set to be featured in Clinical Chemistry. Excitingly, two of these studies will be highlighted at the upcoming #ADLM2024 conference. Step into the poster area for an in-depth exploration! 1️⃣ 📑 Analytical performances of a novel fluorescent immunoassay of anti-Müllerian hormone and establishment of the reference intervals in Chinese children.  🏥 Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine 2️⃣ 📑 Change of sST2 and NT-proBNP levels predict early cardiovascular toxicity in breast cancer patients treated with anthracycline-containing chemotherapy 🏥 Fudan University Shanghai Cancer Center, Shanghai 3️⃣ 📑 Evaluation of IL-6, D-Dimer, and S100β as clinical biomarkers for severity and prognosis of subarachnoid hemorrhage patients: A retrospective study. 🏥 Sichuan Academy of Medical Sciences · Sichuan Provincial People's Hospital 4️⃣ 📑 Establishing a reference interval for soluble ST2 in healthy Chinese Adults and its Analytical Performance in chronic kidney disease coexisting with heart failure. 🏥 HanDan Central Hospital #ADLM2024 #ETHealthcare #ClinicalChemistry #Networking

Medlab Asia 2024 wrapped up last Friday, marking the third international showcase this year for ET Healthcare and Pylon 3D immunoassay analyzer. We engaged with a wider audience and introduced our cutting-edge Pylon platform, highlighting its unparalleled probe technology and response mechanisms that deliver top-notch performance and reliability. If you're intrigued by our products or keen to discuss immune diagnostics challenges, don't hesitate to get in touch. #MedlabAsia2024 #ETHealthcare #Innovation #ImmuneDiagnostics #Networking